A six-year-old girl named Zara has become the first child in Australia to receive an infusion of her own stored cord blood as treatment for cerebral palsy outside of a clinical trial. Experts hope that this milestone will pave the way towards broader availability,...
Managing type 2 diabetes can be a daily challenge, and scientists are always looking for better ways to help patients suffering from the condition. One such area of study is regenerative medicine, more specifically cellular therapy, with researchers investigating...
Researchers are investigating a novel placenta-derived stem cell therapy for multiple sclerosis, a currently incurable degenerative neurological condition. A recent phase 1 clinical trial, with findings published in Scientific Reports, assessed the safety and...
As the world population ages, osteoarthritis (OA), a degenerative, “wear-and-tear” form of arthritis which most often occurs during middle age and onwards,[1] becomes more common and therefore more burdensome. Knee osteoarthritis, in particular, is a major cause of...
Positive early results have emerged from a clinical trial testing an umbilical cord tissue stem cell therapy for epidermolysis bullosa (EB), a currently incurable group of disorders which causes extremely fragile skin. The therapy has shown promise in relieving...
A review paper, newly published in the prestigious Pediatrics journal, statistically demonstrates that cord blood therapy for cerebral palsy is an effective treatment to improve the motor skills of children suffering from this condition. The paper is an analysis of...
First Cord Blood Treatment for Cerebral Palsy Performed in Australia
Could Cord Tissue Stem Cells Help Manage Type 2 Diabetes?
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
Study Shows Improvement From Placenta Stem Cell Injections for Knee Osteoarthritis
Cord Tissue Stem Cell Therapy for Epidermolysis Bullosa Delivers Encouraging Outcomes
